The First-Ever Vaccine For Celiac Disease Has Begun Phase 2 Trials

A vaccine that could enable people with celiac disease to safely consume gluten has begun phase 2 testing in the US, Australia, and New Zealand after more than a decade of development. Results from several phase 1 trials previously showed that the immune system-modifying treatment, called Nexvax2, is safe and…

Continue reading